Department of Internal Medicine IV, Jena University Hospital, Friedrich Schiller University, Jena, Germany; Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
Integrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
J Hepatol. 2024 Dec;81(6):971-982. doi: 10.1016/j.jhep.2024.06.019. Epub 2024 Jun 25.
BACKGROUND & AIMS: Gut bacterial translocation contributes to immune dysfunction and spontaneous bacterial peritonitis (SBP) in cirrhosis. We hypothesized that exposure of peritoneal macrophages (PMs) to bacterial DNA results in type-I interferon (IFN) production, shaping subsequent immune responses, inflammasome activation, and the release of damage-associated molecular patterns (DAMPs).
PMs from patients with cirrhosis were stimulated with E. coli single-stranded DNA (ssDNA), lipopolysaccharide and IFN, or infected with E. coli, S. aureus, and Group B streptococcus in vitro. Cytokine release, inflammasome activation, and DAMP release were quantified by quantitative-PCR, ELISA, western blots, and reporter cells employing primary PMs, monocytes, and caspase-deficient THP-1 macrophages. Serum progranulin concentration was correlated with transplant-free survival in 77 patients with SBP.
E. coli ssDNA induced strong type-I IFN activity in PMs and monocytes, priming them for enhanced lipopolysaccharide-mediated tumor necrosis factor production without inducing toll-like receptor 4 tolerance. During in vitro macrophage bacterial infection, type-I IFN release aligned with upregulated expression of IFN-regulatory factors (IRF)1/2 and guanylate binding proteins (GBP)2/5. PMs upregulated inflammasome-associated proteins and type-I IFN upon E. coli ssDNA exposure and released interleukin-1β upon bacterial infection. Proteomic screening in mouse macrophages revealed progranulin release as being caspase-11-dependent during E. coli infection. PMs and THP-1 macrophages released significant amounts of progranulin when infected with S. aureus or E. coli via gasdermin D in a type-I IFN- and caspase-5-dependent manner. During SBP, PMs upregulated IRF1, GBP2/5 and caspase-5 and higher serum progranulin concentrations were indicative of lower 90-day transplant-free survival after SBP.
Type-I IFN shapes peritoneal immune responses and regulates caspase-5-mediated progranulin release during SBP.
Patients with cirrhosis exhibit impaired immune responses and increased susceptibility to bacterial infections. This study reveals that type-I interferon responses, triggered by pathogen-associated molecular patterns, are crucial in regulating macrophage activation and priming them for inflammatory responses. Additionally, we elucidate the mechanisms by which type-I interferons promote the release of progranulin from macrophages during spontaneous bacterial peritonitis. Our findings enhance understanding of how bacterial translocation affects immune responses, identify novel biomarkers for inflammasome activation during infections, and point to potential therapeutic targets.
肠道细菌易位导致肝硬化患者免疫功能障碍和自发性细菌性腹膜炎(SBP)。我们假设,腹膜巨噬细胞(PMs)暴露于细菌 DNA 会导致 I 型干扰素(IFN)的产生,从而塑造随后的免疫反应、炎症小体激活和损伤相关分子模式(DAMPs)的释放。
我们用大肠杆菌单链 DNA(ssDNA)、脂多糖和 IFN 刺激来自肝硬化患者的 PMs,或者在体外用大肠杆菌、金黄色葡萄球菌和 B 族链球菌感染 PMs。通过定量 PCR、ELISA、western blot 和使用原代 PMs、单核细胞和 caspase 缺陷型 THP-1 巨噬细胞的报告细胞,量化细胞因子释放、炎症小体激活和 DAMPs 释放。在 77 例 SBP 患者中,血清颗粒蛋白浓度与无移植生存相关。
大肠杆菌 ssDNA 在 PMs 和单核细胞中诱导强烈的 I 型 IFN 活性,使它们对脂多糖介导的肿瘤坏死因子产生增强,而不会诱导 Toll 样受体 4 耐受。在体外巨噬细胞细菌感染过程中,I 型 IFN 释放与 IFN 调节因子(IRF)1/2 和鸟苷酸结合蛋白(GBP)2/5 的上调表达相一致。PMs 在大肠杆菌 ssDNA 暴露后上调炎症小体相关蛋白和 I 型 IFN,并在细菌感染后释放白细胞介素-1β。在小鼠巨噬细胞的蛋白质组学筛选中发现,在大肠杆菌感染过程中,颗粒蛋白通过半胱天冬酶-11 释放。金黄色葡萄球菌或大肠杆菌感染 PMs 和 THP-1 巨噬细胞时,通过 gasdermin D 以 I 型 IFN 和半胱天冬酶-5 依赖性方式释放大量颗粒蛋白。在 SBP 期间,PMs 上调 IRF1、GBP2/5 和半胱天冬酶-5,较高的血清颗粒蛋白浓度表明 SBP 后 90 天无移植生存较低。
I 型 IFN 塑造 SBP 期间的腹膜免疫反应并调节 caspase-5 介导的颗粒蛋白释放。
肝硬化患者表现出免疫反应受损和对细菌感染的易感性增加。本研究表明,由病原体相关分子模式触发的 I 型干扰素反应对于调节巨噬细胞激活和为炎症反应做好准备至关重要。此外,我们阐明了 I 型干扰素在自发性细菌性腹膜炎期间促进巨噬细胞释放颗粒蛋白的机制。我们的研究结果增强了对细菌易位如何影响免疫反应的理解,确定了感染期间炎症小体激活的新生物标志物,并指出了潜在的治疗靶点。